One-year outcomes of faricimab for neovascular age related macular degeneration with OCT angiography: focus on resistant and refractory cases
Faricimab demonstrated efficacy and safety in refractory/resistant nAMD, with significant improvements in structural outcomes and stable/improved visual acuity. Extended treatment intervals suggest a potential reduction in treatment burden.
Authors
- Stanislao Rizzo
- Matteo Mario Carlà (ORCID: https://orcid.org/0000-0003-2979-1638)
- Lorenzo Governatori (ORCID: https://orcid.org/0000-0002-6961-8322)
- Roberta Catalani
- Giulia Grieco
- Alessandra Scampoli
- Tomaso Caporossi (ORCID: https://orcid.org/0000-0002-6902-2983)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
Publication Details
- Journal
- International Ophthalmology
- Published
- 2025-08-19
- DOI
- https://doi.org/10.1007/s10792-025-03717-w
- Citations
- 3
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.12
Funders
- Università Cattolica del Sacro Cuore